Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

August 9, 2017

Breast Cancer Genomic Profiling Reveals Clues to Treatment Resistance

Thanks to advances in treatment, the relative five-year survival rate from all combined subtypes of breast cancer now exceeds 90 percent and yet the disease remains the third leading cause of cancer deaths in the United States after lung and colorectal cancers.

By Bill Snyder
x-ray of stomach
August 8, 2017

Early drivers of gastric cancer

Using bioinformatics approaches, Vanderbilt investigators have identified gene expression networks that are deregulated in mouse and human stomach cancers.

By Leigh MacMillan
August 3, 2017

Shinohara’s life and career defined by curiosity

Curiosity is the spark that has always energized and illuminated Eric Shinohara’s life — curiosity about the natural world, about other people and about how to help those individuals.

By VUMC News and Communications
red three darts arrows in the target center
August 3, 2017

Investigators match novel cancer mutations with potential therapies

Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients.

By VUMC News and Communications
August 3, 2017

Nashville Sounds partner with VICC for cancer awareness

The Nashville Sounds baseball team recently highlighted cancer care at Vanderbilt-Ingram Cancer Center (VICC) during a special “Cancer Awareness Night.”

By VUMC News and Communications
July 20, 2017

Study identifies protein’s role in chemotherapy resistance

Researchers at Vanderbilt University Medical Center (VUMC) have discovered a protein that may lead to a new way to prevent resistance and improve outcomes for patients whose cancers have mutations in the tumor suppressor gene BRCA2.

By Bill Snyder
July 13, 2017

Arteaga to direct UT Southwestern cancer center

Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies (C2T2), director of the Breast Cancer Research Program and associate director for Clinical Research at Vanderbilt-Ingram Cancer Center (VICC), has been named director of the Harold C. Simmons Comprehensive Cancer Center and associate dean of Oncology Programs at the UT Southwestern Medical Center in Dallas.
By VUMC News and Communications
July 13, 2017

Kachnic named one of the ‘Women to Watch’ in health care

Lisa Kachnic, M.D., Cornelius Vanderbilt Chair in Radiation Oncology and chair of the Department of Radiation Oncology at Vanderbilt University Medical Center (VUMC), has been named one of the “Women to Watch” in health care by Nashville Medical News.
By VUMC News and Communications
July 12, 2017

Conference to focus on link between viruses and cancer

The association between tobacco use and cancer is well known. But there are other risk factors for cancer that are less recognized, including the link between cancer and certain viruses.
By VUMC News and Communications
June 22, 2017

Hackett elected to leadership role for national cancer group

Lauren Hackett, MPA, executive director of Administration and chief business officer for Vanderbilt-Ingram Cancer Center (VICC), has been elected to serve on the Finance Committee for the National Comprehensive Cancer Network (NCCN).
By VUMC News and Communications
June 19, 2017

STINGing combination for cancer

A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer.
By VUMC News and Communications
June 15, 2017

VICC racers compete in downtown bed race for cancer research funding

By VUMC News and Communications
June 13, 2017

Cancer patient chooses Nashville for VICC care and the Nashville Predators

Los Angeles native Christina Shaw had two powerful goals when she decided to move cross country to live in Nashville – the first was to support her favorite hockey team and the second was to meet a renowned lung cancer specialist at Vanderbilt-Ingram Cancer Center.
By VUMC News and Communications